Sergi Barrull Email & Phone Number

Verona, It

Boston, Ma, Us

Indigo is a Boston-based unicorn start-up with the goal to make agriculture more sustainable, reverse climate change and improve farmers profitability through 3 offers:i) Biological technologiesii) Carbon, a digitally-enabled program to sequester CO2 and rewards farmers with carbon credits iii) Market+, an online platform to buy/sell grain commodities Currently leading Indigo Biologicals Business Unit in Europe with focus on marketing a bio-stimulants, bio-fertilizers and bio-controls portfolio:📌 Green-field start-up operation: defined strategy and started business in Europe completely from scratch in a highly entrepreneurial, hands-on environment. 📌 Market entry launches: launched Indigo in Germany and Turkey within 4 months from start in 2019, Hungary and Ukraine were launched in 2020, currently preparing expansion into Romania, Czech, Slovakia, Poland, Bulgaria, Spain and Italy.📌 Sales team leadership: assembled team of highly experienced country commercials heads and key account managers across Europe, set up lead and sales management process, ran +25 country sales campaigns in 4 years, grew business 2-4x p.a. 📌 Go-to-market partnership strategy: implemented locally-adapted distribution strategies to optimize business traction and footprint, using a mix of national distributors, retailers and wholesalers, as needed. Also, seeking partnerships with major players in the industry.📌 Portfolio strategy: designed overall portfolio strategy and launched Biotrinsic N-Collect, PK-Release, i30FP, i30WD, i39FP, i177FP, i280FP as water and nutrient use efficiency products. Currently shaping mid-term portfolio strategy and pipeline, including bio-pesticides. 📌 Marketing/ demand generation strategy: designed and steered demand generation activities to create pull for Indigo products at end-user level, using a mix of in-field and online promotion campaigns.📌 P&L accountability: from sales targets to EBITDA and cash flow

Basel, Basel, Ch

Overall marketing, business development, strategy and P&L accountability for biotechnology and seeds BU in Brazil and Argentina, leading a commercial transformation and financial turnaround followed by a major strategic M&A:📌 P&L accountability: active management of business P&L (sales to GP, R&D spend, write-offs)📌 Marketing management: responsible for product positioning, pricing, innovation cycle, new product introductions and future mid to long term portfolio design and R&D investments 📌 New business models: redefined go-to-market strategy, business model and value proposition to optimize market access, growth and profitability while minimizing risk📌 GM/ Biotechnology strategy development: fully assessed commercial, technical, regulatory drivers to define GM/ biotechnology strategy to maximize foresighted M&A value creation 📌 M&A: led strategic thinking and process for largest acquisition in Syngenta’s history, moving from a distant #5 to a leading #2 position in LATAM Soybeans. Supported M&A integration process, aligned strategy and handed over accountabilities to new leadership.📌 Licensing/ partnerships: managed partnerships with local and global player to out-licensing proprietary GM/ biotechnology traits as well to in-license third party’s technology, achieving signature of key commercial agreements📌 Leadership: led cross-functional team within operating unit model, ensuring efficient end-to-end business execution across R&D, marketing, production & supply.

Basel, Basel, Ch

Global $2.5bn business unit integrating agro chemicals, biotechnology and seeds with focus on USA and LATAM:📌 Strategy development: assessed strategic alternatives to bring Soybean BU towards a value creation path. Proposed a turnaround plan that included new business models and re-prioritized R&D investment, overall optimizing strategic fit and risk/ reward equation. The produced materials and analysis, presented at Senior Executive level, were of highest quality standard, achieved full support and strategy was implemented through 2015-18 period. 📌 Strategic planning: responsible for producing Global BU market assumptions and financial plans, from 5-year plans to 15-year strategic outlooks, in line with corporate planning requirements.📌Business development/ Licensing: contributed to biotechnology licensing and partnerships strategy definition and followed through key licensing agreements

Basel, Basel, Ch

Commercial accountability for a biological products portfolio, organized as a standalone business, separate from main Syngenta, sales ~$50-100m in +10 countries, focused on the fruits and vegetables segment, mainly in EAME:📌 Accountability: overall strategy and commercial accountability reporting to BU Head📌 Strategy development: defined and implemented new BU strategy to drive growth & profitability, aligning strategic priorities across R&D, production and marketing. 📌 Product Management: led overall efforts to upskill BU marketing excellence. Designed product value propositions, segmented markets and defined product positioning. Additionally managed new product launches and optimized overall portfolio range. 📌Business development/ licensing: scanned new technology companies, established partnerships, managed third-party relationships and negotiated licensing deals to enhance portfolio range.📌 Profitability: Bioline business unit EBITDA doubled within 2011-2013, completing a successful business turnaround in a highly competitive market environment📌 Leadership: led/ coordinated in-country marketing leads / technical experts related to Bioline BU

Basel, Basel, Ch

Led strategic and commercial excellence projects within $2bn Syngenta agro chemicals division in region Europe, Africa and Middle East:📌 Go-to-market strategy: led projects in various countries such Ukraine, Belgium, Turkey to review sales force/ distribution performance and implement key go-to-market optimizations.📌 New business models: led commercial pilots in Spain and Ukraine to assess a new business model integrating the Crop Protection and Seeds units into one sales & marketing model. 📌 M&A/ VC: assessed biologicals companies’ landscape and pursued selected M&A/ VC targets.📌 Strategic agenda implementation: supported senior leadership team to define EAME strategic agenda and establish PMO process to track cross-functional strategic initiatives

Männedorf, Zh, Ch

Medical diagnostics industry analysis and market entry strategy for offer combining TECAN high throughput diagnostics equipment and newly acquired REM diagnostics warehousing solution.

Clarens, Ch

Growth strategy project for smart meter reader equipment start-up within energy management industry.

Dublin 2, Ie

📌 Provided consulting in sales and marketing, CRM/ customer services, Order-to-Cash📌 Strong project management experience within pan-European implementations📌 Led multinational teams of up to 10 project members📌 Served clients in fast moving consumer goods industry (FMCG)

Master Of Business Administration (Mba), Lausanne, Switzerland

Executive Training: Marketing & Sales Excellence Academy, Fontainebleau, France

Bsc In Business Administration (Diplomatura En Ciencias Empresariales), Barcelona, Spain

Graduation Thesis (Diplomarbeit) For Msc In Industrial Engineering, Berlin, Germany

Msc In Industrial Engineering, Barcelona (Etseib), Spain